TransAct reports a significantly better Q3 report with a 63% increase in net sales.

[MiaLuca]

Net sales for the third quarter of 2017 were $10.6 million, while they are expected to be $17.9 million in 2022. Its adjusted EBITDA was $1.2 million, a significant increase from the - $1.2 million in 2021.
Overall, TransAct's financials appear strong, particularly the adjusted EBITDA rebound, which CEO Bart Shuldman highlighted in the report: "Our quarterly results broke not only a number of company sales records but also marked the end of our best nine months in sales since 2018."

 

[gwolf666]

TransAct reported net sales of $10.6 million in Q3 2017, with a projected rise to $17.9 million in 2022. Adjusted EBITDA saw a significant recovery, jumping from -$1.2 million in 2021 to $1.2 million. CEO Bart Shuldman celebrated the results, noting record-breaking quarterly sales and the company’s best nine-month performance since 2018.